ExpressBusinessLoans.com Will Begin Accepting Applications for the SBA Paycheck Protection Program
NEW YORK, April 10, 2020 /PRNewswire/ -- ExpressBusinessLoans.com, a nationwide provider of working capital, commercial and non-owner occupied residential real estate mortgages, SBA loans, and alternative business financing, has announced that it will begin accepting applications for the Paycheck Protection Program (PPP).
"Small businesses should move quickly to secure working capital" said Michael Martin, Managing Partner of ExpressBusinessLoans.com. "We have worked with several small businesses over the past week to ensure that they can secure approvals and proceed to funding. Underwriting criteria has changed but we have stayed abreast of any changes and will continue to work with small businesses as they deal with uncertainty."
The SBA has announced several programs to mitigate the current economic situation caused by the Coronavirus outbreak. Small businesses can turn to ExpressBusinessLoans.com for SBA options as well as bridge financing in the interim. "We have seen an increase in inquiries across industries. Particularly healthcare, construction, and e-commerce" said Mr. Martin. In order to secure the best chance of approval he also advised small business owners to gather their most recent small business financial information including recent banking transaction data.
Small business owners interested in learning more about their available options are invited to contact ExpressBusinessLoans.com directly at [email protected] or visit https://ExpressBusinessloans.com.
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...